Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Pasqua Papappicco
Observed names:
P. Papappicco,
P.P. Papappicco,
Papappicco, P.,
Papappicco, P. P.,
Papappicco, Pasqua
Institution:
University of Bari Aldo Moro
Observed institution:
University of Bari Aldo Moro
OpenAlex ID:
A5010673149
A phase 2 study of a novel transforming growth factor-beta (TGF-β1) receptor I kinase inhibitor, LY2157299 monohydrate (LY), in patients with advanced hepatocellular carcinoma (HCC).
2014
·
Sandrine J. Faivre
, Armando Santoro
, et al.
·
Journal of Clinical Oncology
·
49
Randomized dose comparison phase II study of the oral transforming growth factor-beta (TGF-ß) receptor I kinase inhibitor LY2157299 monohydrate (LY) in patients with advanced hepatocellular carcinoma (HCC).
2013
·
Sandrine J. Faivre
, Armando Santoro
, et al.
·
Journal of Clinical Oncology
·
8
EVALUATION OF LY2157299 MONOHYDRATE (LY), A TGF-β RECEPTOR I KINASE INHIBITOR, IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA: PHASE 2 STUDY RESULTS OF SAFETY, EFFICACY AND PK/PD
2014
·
G. Giannelli
, S. Faivre
, et al.
·
Journal of Hepatology
·
6
Prevalence of Irritable Bowel Syndrome in Celiac Patients on Gluten Free Diet
2011
·
G. Lorusso
, S. Castellaneta
, et al.
·
Digestive and Liver Disease
·
2
Show more works
View as search
Works count:
7
Citation count:
69
H-index:
4
I10-index:
1
Year
Topic
Type